| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Sep'18 | Jun'18 |
|---|---|---|---|---|---|---|
Operating Expenses: | ||||||
Research and development | ||||||
11,417 | 11,596 | 16,836 | 11,955 | 8,411 | 4,599 | 3,207 |
General and administrative | ||||||
7,862 | 6,955 | 4,452 | 3,713 | 1,885 | 920 | 959 |
Operating loss | ||||||
-19,279 | -18,551 | -21,288 | -15,668 | -10,296 | -5,519 | -4,166 |
Change in fair value of derivative liabilities | ||||||
- | - | 0 | 0 | - | 0 | 0 |
Other income | ||||||
210 | - | - | - | 0 | - | - |
Interest income | ||||||
494 | 710 | 989 | 565 | 351 | 320 | 222 |
Interest expense | ||||||
- | - | 0 | 0 | - | 0 | 0 |
Total other income | ||||||
704 | 710 | 989 | 565 | 351 | 320 | 222 |
Net loss | ||||||
-18,575 | -17,841 | -20,299 | -15,103 | -9,945 | -5,199 | -3,944 |
Net loss per share | ||||||
Basic and Diluted | ||||||
-0.56 | 0.71 | -0.62 | -0.58 | -1.73 | -0.99 | -0.19 |
Weighted average shares outstanding: | ||||||
Basic and Diluted | ||||||
33,267 | 49,162 | 32,864 | 26,212 | 5,740 | 5,244 | 20,326 |